ExploreWatchlistsPricing
  1. JP-listed companies
  2. Shionogi & Co.,Ltd.
  3. Financials
  4. Payments for dividends

Shionogi & Co.,Ltd. (4507)

Market cap
¥2.67T
P/E ratio
12.2x
Develops, manufactures and sells prescription pharmaceuticals globally, specializing in infectious diseases and central nervous system disorders.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndPayments for dividends (Million JPY)YoY (%)
Mar 31, 2026-56,175+15.35%
Mar 31, 2025-48,698+10.99%
Mar 31, 2024-43,876+21.40%
Mar 31, 2023-36,142+9.04%
Mar 31, 2022-33,146+1.90%
Mar 31, 2021-32,529+4.52%
Mar 31, 2020-31,122+12.60%
Mar 31, 2019-27,639+14.05%
Mar 31, 2018-24,235+9.60%
Mar 31, 2017-22,112+21.39%
Mar 31, 2016-18,216+13.42%
Mar 31, 2015-16,060

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat